AzTrials
AzTrials

Strength Training EffectsNCT06813404

Building Strength for Menopause

A study testing Heavy resistance training and Yoga in people with Strength Training Effects and Menopausal Women, run by Northeastern University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

A pilot study investigating whether heavy resistance training is enjoyable, acceptable, and feasible for middle-aged women undergoing the menopausal transition. Additional outcomes to be assessed include changes to strength and muscle composition as well as changes to cognitive function and self-reported measures of… Read more about this study

Who is it for?
Ages 40 to 60 years, women onlyHealthy volunteers can take part
What is being tested?
Heavy resistance training and Yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Mar 2025to 1 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 40-60 years of age at study enrollment
  • Currently experiencing symptoms related to menopause
  • Low physical activity levels at study enrollment (not meeting CDC guidelines of 150 minutes moderate/75 minutes vigorous activity per week)
  • No regular (>1x per week) participation in heavy resistance training or yoga exercise within the past 6 months
  • Physician's consent to participate in strength testing and the exercise program (if deemed necessary)
  • Ambulatory
Show all 12Show fewer
  • Absence of health conditions that may be exacerbated by exercise
  • Good or corrected vision and hearing
  • Intention to remain in the Boston area for the duration of the study
  • Willingness to complete study assessments
  • Ability to read, write and understand English
  • Not currently enrolled in another PA study

Who cannot join

  • Under 40 or over 60 years
  • Pregnant or planning to become pregnant
  • Moderate to high physical activity levels at enrollment (meeting CDC guidelines)
  • Currently participating regularly (>1x per week) in a heavy resistance training or yoga program
  • Non-consent of physician (if deemed necessary)
  • Non-ambulatory (e.g. use of walkers, wheelchairs)
Show all 11Show fewer
  • Presence of health conditions that may be exacerbated by exercise (arthritis, musculoskeletal disorders, etc.)
  • Problems with vision or hearing
  • Intent to move or take an extended (>2 weeks) vacation during the testing time points (baseline, 4 months)
  • Unwilling to complete study assessments
  • Currently enrolled in another PA study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Northeastern University

    Boston, Massachusetts, 02115

Other trials in United States

About this study

A pilot study investigating whether heavy resistance training is enjoyable, acceptable, and feasible for middle-aged women undergoing the menopausal transition. Additional outcomes to be assessed include changes to strength and muscle composition as well as changes to cognitive function and self-reported measures of fatigue, cognition, self-efficacy, and mood.

Being tested
Heavy resistance training, Yoga
Keywords
menopausal women, strength training, cognitive function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heavy resistance trainingBehavioural

    The heavy resistance training intervention will consist of twice weekly exercise sessions of 60 minutes each.

  • YogaBehavioural

    Twice weekly yoga sessions of 60 minutes each

Study groups in NCT06813404
Study groupRoleWhat they receive
First wave of participants (n=30)ExperimentalThis arm is the first round of the exercise intervention, conducted with half (n=30) the anticipated number of participants.
Receives: Behavioral: Heavy resistance training; Behavioral: Yoga
Second wave of participants (n=30)ExperimentalThis arm is the second round of participants (n=30) who will receive the same intervention as the first wave.
Receives: Behavioral: Heavy resistance training; Behavioral: Yoga

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility (adherence)

    Adherence to the study intervention will be evaluated at the end of each arm, based on recorded attendance. It will be recounted as a percentage.

    Measured: From enrollment to the end of the exercise intervention at 16 weeks

  2. Feasibility (retention)

    Retention of participants in each group will be evaluated at the end of each arm, based on recorded attendance. It will be recounted as a percentage.

    Measured: From enrollment to the end of the exercise intervention at 16 weeks

  3. Acceptability

    Participant enjoyment will be evaluated at the end of each arm, based on self-reported enjoyment after each session, and a final survey for participant feedback on the intervention. Enjoyment will be rated on a Likert scale.

    Measured: From enrollment to the end of the exercise intervention at 16 weeks

Secondary outcomes (4)
  1. Muscular strength

    Assessed through 1-repetition maximum testing of two compound lifts: barbell box squat and barbell bench press. Tests will be conducted at baseline and at the end of the intervention for both exercise groups.

    Measured: From baseline testing to the end of the exercise intervention at 16 weeks

  2. Cognitive function (executive function)

    The Digit Symbol Substitution test will be used to assess components of executive function such as processing speed, working memory, visuospatial processing, and attention. This is recorded as total number of trials and total number of correct trials in 90 seconds.

    Measured: From baseline testing to the end of the exercise intervention at 16 weeks

  3. Cognitive function (working memory)

    The Backward Digit Span test will be used to assess working memory and attention. This test is scored as the longest sequenced reached and passed and the total number of attempts.

    Measured: From baseline testing to the end of the exercise intervention at 16 weeks

  4. Cognitive function (memory recall)

    The East Boston Memory Test will be used to assess immediate and delayed recall. The test is scored as the correct number of components recalled from a three-sentence story.

    Measured: From baseline testing to the end of the exercise intervention at 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2025
  2. Study start1 Mar 2025 (estimated)
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Why it stopped: Unfunded

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Feasibility pilot study of heavy resistance training for middle-aged, menopausal women.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06813404
Sponsor's protocol ID
IRB# 24-12-12
Status last verified
May 2025
First submitted
27 Jan 2025
Last updated
7 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be de-identified

Questions about this trial

What is this clinical trial studying?

A study testing Heavy resistance training and Yoga in people with Strength Training Effects and Menopausal Women, run by Northeastern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 7 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility (adherence) (time frame: From enrollment to the end of the exercise intervention at 16 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in